fda removes tirzepatide from shortage list Says Compounded Must Exit the Market GLP-1 Drugs: FDA “Re-Confirms” Decision

pharmacies, it has become widely available

Methods: We described a case series of patients experiencing AP while on GLP-1 RAs

Kim JS, Yang JW, Yoo JS et al (2017) Association between E/e ratio and fluid overload in patients with predialysis chronic kidney disease

Change from baseline at 6-month follow-up in variables including HbA 1c , weight/BMI, estimated glomerular filtration rate (eGFR), lipid profile, and liver function were examined

Patients who incorporate strength training while using GLP-1 medications preserve more muscle mass and maintain higher metabolic rates

Compared with drug therapy, such as nimodipine or citicoline, acupuncture therapy can significantly improve the MoCA score of PSCI patients (Wang et al., 2016